4th Antigen-Specific Immune Tolerance Drug Development

  • 27-28 Jan 2021
  • Online Event

Description

The 4th Antigen-Specific Immune Tolerance Drug Development is dedicated to safe and effective antigen-specific immune tolerance therapies.

The 4th Antigen-Specific Immune Tolerance Drug Development covers topics such as:

  • Analyzing the Scope & Strategies to Antigen-Specific Immune Tolerance
  • Dynamics of Underlying Causes & Current Understandings of Autoimmunity
  • Improving the Pre-Clinical Predictability of Antigen-Specific Immune Tolerance Therapies
  • Identification, Validation & Targeting of Specific Antigens for Immune Tolerance Therapies
  • Optimizing Clinical Development & Paving the Future of Antigen-Specific Immune Tolerance Therapies
  • Surging Translational Potentials of Pre-Clinical Antigen-Specific Therapies
  • Commercialization: Future Proofing Immune Tolerance Therapies for Patients

The 4th Antigen-Specific Immune Tolerance Drug Development is being held on 27-28 Jan 2021.

More Details

Prices:
998-2999 US Dollar
Exhibition:
No exhibition
Organizer:
Hanson Wade
Website:

Future Events

  • 4th Antigen-Specific Immune Tolerance Drug Development - 27-28 Jan 2021, Online Event (73896)
  • 5th Antigen-Specific Immune Tolerance Drug Development - 2022 (81459)

Past Events

  • 3rd Antigen-Specific Immune Tolerance Drug Development - 25-27 Feb 2020, Colonnade Hotel, Boston, MA, United States (81461)

Important

Please, check the official conference website for possible changes, before you make any traveling arrangements

Prices are for evaluation only.

Other Events with Similar Categories

Other Events with Similar Location or Organizer

Featured Conferences & Exhibitions